Estella Matutes - Concepedia

Author

Estella Matutes

Also Known As

E Matutes, E. MATUTES, E. Matutes, ESTELLA MATUTES, Estela Matutes, Estella M., Estella Matutes, Estella Matutes, MD, PhD, Estel·la Matutes, Matutes Estella

454

Publications

19.1K

Citations

H-Index

Concepts

All Affiliations

Royal Marsden Hospital Institute of Cancer Research Royal Marsden NHS Foundation Trust Royal Bournemouth Hospital Hospital Clínic de Barcelona

About

Estella Matutes is an author at Royal Marsden Hospital specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	72	4.8K
2	Health Sciences	14	16	1.3K
3	Public Health	3	3	120
4	Allergy	2	2	188
5	Engineering	1	1	69

Estella Matutes

192

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Estella Matutes, K Owusu-Ankomah, Ricardo Morilla, PubMed	1994	796
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial Daniel Catovsky, Estella Matutes, R. F. Bezares, The Lancet Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukaemiaMedicine	2007	678
Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b) E Moreau, Estella Matutes, Roger A’Hern, American Journal of Clinical Pathology	1997	401
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia Maria Chiara Di Bernardo, Dalemari Crowther-Swanepoel, Peter Broderick, Nature Genetics Genome-wide Association StudyDisease SusceptibilityChronic Lymphocytic LeukemiaMedicineGenetics	2008	359
Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Lia Ginaldi, Massimo De Martinis, Estella Matutes, Journal of Clinical Pathology	1998	325
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H Claire Dearden, Estella Matutes, Bruno Cazin, Blood	2001	315
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification Estella Matutes, Winfried F. Pickl, Mars van’t Veer, Blood	2011	309
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease Jenny Orchard, Richard Garand, Zadie Davis, Blood	2003	293
Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis Monica Else, Claire Dearden, Estella Matutes, British Journal of Haematology	2009	264
Mutational Status of the <i>TP53</i> Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial David González, Pilar Martı́nez, Rachel Wade, Journal of Clinical Oncology	2011	263

Page 1